Corneal edema and epithelial defect during pralsetinib treatment
Journal of Oncology Pharmacy Practice
Published online on September 29, 2025
Abstract
Journal of Oncology Pharmacy Practice, Ahead of Print.
IntroductionThis article describes an unusual case of corneal edema with epithelial defect associated with pralsetinib, an oral rearranged during transfection (RET) inhibitor and used for the treatment of metastatic RET fusion-positive non–small cell lung ...
IntroductionThis article describes an unusual case of corneal edema with epithelial defect associated with pralsetinib, an oral rearranged during transfection (RET) inhibitor and used for the treatment of metastatic RET fusion-positive non–small cell lung ...